Correlation Between Biocardia and Applied Molecular

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Biocardia and Applied Molecular at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biocardia and Applied Molecular into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biocardia and Applied Molecular Transport, you can compare the effects of market volatilities on Biocardia and Applied Molecular and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biocardia with a short position of Applied Molecular. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biocardia and Applied Molecular.

Diversification Opportunities for Biocardia and Applied Molecular

-0.3
  Correlation Coefficient

Very good diversification

The 3 months correlation between Biocardia and Applied is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Biocardia and Applied Molecular Transport in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Applied Molecular and Biocardia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biocardia are associated (or correlated) with Applied Molecular. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Applied Molecular has no effect on the direction of Biocardia i.e., Biocardia and Applied Molecular go up and down completely randomly.

Pair Corralation between Biocardia and Applied Molecular

Given the investment horizon of 90 days Biocardia is expected to under-perform the Applied Molecular. In addition to that, Biocardia is 1.93 times more volatile than Applied Molecular Transport. It trades about -0.02 of its total potential returns per unit of risk. Applied Molecular Transport is currently generating about 0.01 per unit of volatility. If you would invest  34.00  in Applied Molecular Transport on September 2, 2024 and sell it today you would lose (1.00) from holding Applied Molecular Transport or give up 2.94% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy8.06%
ValuesDaily Returns

Biocardia  vs.  Applied Molecular Transport

 Performance 
       Timeline  
Biocardia 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biocardia has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's fundamental indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Applied Molecular 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Applied Molecular Transport has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Applied Molecular is not utilizing all of its potentials. The recent stock price confusion, may contribute to short-horizon losses for the traders.

Biocardia and Applied Molecular Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Biocardia and Applied Molecular

The main advantage of trading using opposite Biocardia and Applied Molecular positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biocardia position performs unexpectedly, Applied Molecular can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Applied Molecular will offset losses from the drop in Applied Molecular's long position.
The idea behind Biocardia and Applied Molecular Transport pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios